Baclofen

The brand product was first FDA-approved before 1982, and the first generic was approved May 6, 1988. FDA's Orange Book lists 51 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $89 million on Baclofen across 5.2 million claims for 1.4 million beneficiaries.

Baclofen is available as 114 NDCs from 24 manufacturers (111 generic, 3 brand), with NADAC prices from $0.03 to $3.45 per EA — the most expensive product costs about 110× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.